238 related articles for article (PubMed ID: 35616275)
21. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
23. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
25. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
26. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
[TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.
Wang Y; Li K; Zhao W; Liu Z; Liu J; Shi A; Chen T; Mu W; Xu Y; Pan C; Zhang Z
Cell Death Dis; 2021 Dec; 12(12):1158. PubMed ID: 34907179
[TBL] [Abstract][Full Text] [Related]
28. Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study.
Li R; Chen B; Chen Z; Su Q; He Q; Yang J; Xu P; Hu J; Jin Y; Bo Z
Eur J Surg Oncol; 2024 Apr; 50(4):108246. PubMed ID: 38484491
[TBL] [Abstract][Full Text] [Related]
29. Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Yousaf A; Kim JU; Eliahoo J; Taylor-Robinson SD; Khan SA
J Clin Exp Hepatol; 2019; 9(6):740-748. PubMed ID: 31889756
[TBL] [Abstract][Full Text] [Related]
30. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
[TBL] [Abstract][Full Text] [Related]
31. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.
Rodrigues V; Landi F; Castro S; Mast R; Rodríguez N; Gantxegi A; Pradell J; López-Cano M; Armengol M
J Gastrointest Surg; 2021 Jun; 25(6):1388-1403. PubMed ID: 32661833
[TBL] [Abstract][Full Text] [Related]
32. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
[TBL] [Abstract][Full Text] [Related]
33. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
[TBL] [Abstract][Full Text] [Related]
34. Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma.
Xu L; Wang P; Zhang W; Li W; Liu T; Che X
Front Oncol; 2021; 11():757498. PubMed ID: 34660327
[TBL] [Abstract][Full Text] [Related]
35. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.
Yasuta S; Sugimoto M; Kudo M; Kobayashi S; Takahashi S; Konishi M; Gotohda N
BMC Cancer; 2022 Dec; 22(1):1358. PubMed ID: 36578076
[TBL] [Abstract][Full Text] [Related]
36. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract][Full Text] [Related]
37. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of body composition in patients with digestive tract cancers: A prospective cohort study of 8,267 adults from China.
Han J; Liu X; Wang J; Tang M; Xu J; Tan S; Liu X; Wu G
Clin Nutr ESPEN; 2024 Aug; 62():192-198. PubMed ID: 38901941
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
40. Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
Pring ET; Malietzis G; Gould LE; Lung P; Drami I; Athanasiou T; Jenkins JT
Eur J Surg Oncol; 2022 Jul; 48(7):1664-1670. PubMed ID: 35339340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
